Astera Labs, Inc.
ALAB Nasdaq· Semiconductors & Related Devices
Last close · Oct 23, 2026
$257.16
KIRA · Stoqly’s AI analyst, in plain words
- Astera Labs, Inc. had $853M of revenue in fiscal 2025, up 115.1% on the year before.
- Its operating margin was 20.3%, up 49.6 pts: of every 100 in sales, about 20 is left after running the business.
- Astera Labs, Inc. made $219M of net profit in fiscal 2025.
- Free cash flow was $282M in fiscal 2025, 33.1% of revenue.
- Astera Labs, Inc. returned $0.0M to shareholders in fiscal 2025, 0% of free cash flow. The diluted share count rose 36.8%.
Market cap
$47.1B
P/E
127.3x
Revenue
$853M
Net income
$219M
Free cash flow
$282M
Operating margin
20.3%
Astera Labs, Inc. in 30 seconds · fiscal 2025
Are sales growing?
+115.1%
Yes. Sales grew 115.1% last year.
Does it make a profit?
25.7%
Yes. It keeps 25.7% of every sale as profit.
Does profit turn into cash?
33.1%
Yes. 33.1% of sales ends up as free cash.
How healthy are the accounts?
5 / 8
Mixed. It passes 5 of 8 health tests.
How is the share priced?
127.3x
One share costs 127.3 times its yearly profit per share.
What Astera Labs, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 20, 2026
- Legal name
- Astera Labs, Inc.
- CIK
- 0001736297
Astera Labs, Inc. · ALAB
Results and finances
The last 4 fiscal years. Amounts in USD.
| Fiscal year | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Sales and profit | ||||
| Revenue | $79.9M | $116M | $396M | $853M |
| Revenue growth | — | 45.0% | 242.2% | 115.1% |
| Gross margin | 73.5% | 68.9% | 76.4% | 75.7% |
| Operating margin | −75.4% | −25.5% | −29.3% | 20.3% |
| Net income | −$58.3M | −$26.3M | −$83.4M | $219M |
| Net margin | −73.0% | −22.7% | −21.1% | 25.7% |
| Diluted EPS | −$1.71 | −$0.71 | −$0.64 | $1.22 |
| Cash | ||||
| Cash from operations | −$35.9M | −$12.7M | $137M | $319M |
| Capital expenditure | $3.9M | $2.8M | $34.2M | $37.5M |
| Free cash flow | −$39.8M | −$15.5M | $102M | $282M |
| FCF margin | −49.8% | −13.4% | 25.8% | 33.1% |
| Share buybacks | $0.3M | $0.2M | $1.1M | $0.0M |
| Share count change | — | 8.7% | 253.5% | 36.8% |
| Debt and strength | ||||
| Cash and short-term investments | $76.1M | $149M | $914M | $1.2B |
| Shareholders' equity | −$85.3M | −$97.7M | $965M | $1.4B |
| Current ratio | — | 5.3x | 11.7x | 10.2x |
| Returns and quality | ||||
| Return on equity | — | — | −19.2% | 18.8% |
| Return on tangible equity | — | — | −8.6% | 16.3% |
| Piotroski F-score | — | — | 5 | 5 |
| Altman Z'' | — | −0.7 | 15.7 | 14.6 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$782M
8 insiders
Of sales under plans
79%
$618M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Astera Labs, Inc. · ALAB
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $257.16 a share, the company is worth $47.1B: 127.3 times its earnings of the last four quarters.
Source: SEC EDGAR XBRL filings (CIK 0001736297). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.